Data Sheet - Medsafe
Data Sheet Rubifen Rubifen SR Methylphenidate hydrochloride (USP) 5 mg, 10 mg and 20 mg immediate release tablets Methylphenidate hydrochloride (USP) 20 mg sustained release tablets
Download Data Sheet - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Guideline on quality of oral modified release products
www.ema.europa.euThe quality of a prolonged release dosage form is continuously improved during the development of a new drug product. The choice of the composition is made during the development based on small -scale
Silicones for Mold Release - Latro
www.latro.com.trSilicones for Mold Release Peter Stevens Application Development Manager Fluids / Industrial
DATA SHEET ADALAT 10 / ADALAT 20 Presentation
www.medsafe.govt.nz160509 Adalat DS.doc 1 . DATA SHEET . ADALAT ® 10 / ADALAT ® 20 . nifedipine. Name of Medicine. Adalat 10 (nifedipine) modified release tablets Adalat 20 (nifedipine) modified release tablets
Attia 200 mg Modified-Release Capsules, Hard (dipyridamole ...
www.mhra.gov.ukUKPAR Attia 200 mg Modified-Release Capsules, Hard PL 08553/0458 1 Attia 200 mg Modified-Release Capsules, Hard (dipyridamole) PL 08553/0458
Public Assessment Report UKPAR Trazodone Hydrochloride ...
www.mhra.gov.ukTrazodone Hydrochloride 100mg/5ml Oral Solution PL 31862/0027 3 Children and adolescents Trazodone Oral Solution should not be used in children and adolescents under 18 years of age.
MULTISOURCE (GENERIC) PHARMACEUTICAL PRODUCTS: …
www.who.intWorking document QAS/14.583/Rev.1 page 3 43 BACKGROUND 44 Over the course of time and especially in view of the implementation of the existing 45 guidelines 1 the users have indicated that there was a need to review and update certain 46 requirements.